245 related articles for article (PubMed ID: 7558957)
41. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.
DeAngelis LM; Seiferheld W; Schold SC; Fisher B; Schultz CJ;
J Clin Oncol; 2002 Dec; 20(24):4643-8. PubMed ID: 12488408
[TBL] [Abstract][Full Text] [Related]
42. Primary central nervous system lymphoma in Japan: a nationwide survey.
Hayabuchi N; Shibamoto Y; Onizuka Y
Int J Radiat Oncol Biol Phys; 1999 May; 44(2):265-72. PubMed ID: 10760418
[TBL] [Abstract][Full Text] [Related]
43. Phase II trial of temozolomide plus concurrent whole-brain radiation followed by TNV regimen as adjuvant therapy for patients with newly diagnosed primary CNS lymphoma.
Wang Y; Liu B; Xu D; Zhao H; Zhu Y; Xu J; Tao R
Neurol India; 2013; 61(3):260-4. PubMed ID: 23860145
[TBL] [Abstract][Full Text] [Related]
44. Long-term follow-up of a CHOP-based regimen with maintenance therapy and central nervous system prophylaxis in lymphoblastic non-Hodgkin's lymphoma.
Colgan JP; Andersen J; Habermann TM; Earle JD; O'Connell MJ; Neiman RS; Mann RB; Glick JH
Leuk Lymphoma; 1994 Oct; 15(3-4):291-6. PubMed ID: 7866277
[TBL] [Abstract][Full Text] [Related]
45. Therapy of PCNSL at the Massachusetts General Hospital with high dose methotrexate and deferred radiotherapy.
Hochberg FH; Tabatabai G
Ann Hematol; 2001; 80 Suppl 3():B111-2. PubMed ID: 11757690
[No Abstract] [Full Text] [Related]
46. [Clinical study of primary central nervous system lymphoma: the role of chemotherapy].
Maeda Y; Matsumoto K; Kuriyama M; Ono Y; Kunishio K; Tamiya T; Furuta T; Ohmoto T
Gan To Kagaku Ryoho; 1997 May; 24(7):807-13. PubMed ID: 9170518
[TBL] [Abstract][Full Text] [Related]
47. Secondary analysis of Radiation Therapy Oncology Group study (RTOG) 9310: an intergroup phase II combined modality treatment of primary central nervous system lymphoma.
Fisher B; Seiferheld W; Schultz C; DeAngelis L; Nelson D; Schold SC; Curran W; Mehta M
J Neurooncol; 2005 Sep; 74(2):201-5. PubMed ID: 16193393
[TBL] [Abstract][Full Text] [Related]
48. Importance of radiotherapy in the outcome of patients with primary CNS lymphoma: an analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments.
Bessell EM; López-Guillermo A; Villá S; Verger E; Nomdedeu B; Petit J; Byrne P; Montserrat E; Graus F
J Clin Oncol; 2002 Jan; 20(1):231-6. PubMed ID: 11773174
[TBL] [Abstract][Full Text] [Related]
49. Combined therapy for primary central nervous system lymphoma in immunocompetent patients.
Ferreri AJ; Reni M; Bolognesi A; Verusio C; Villa E
Eur J Cancer; 1995 Nov; 31A(12):2008-12. PubMed ID: 8562157
[TBL] [Abstract][Full Text] [Related]
50. Weekly CHOP for the treatment of advanced intermediate and high-grade non-Hodgkin's lymphoma.
Shimizu K; Hara K; Kunii A
Am J Clin Oncol; 1989 Jun; 12(3):195-200. PubMed ID: 2729176
[TBL] [Abstract][Full Text] [Related]
51. Systemic chemotherapy with vincristine, cyclophosphamide, doxorubicin and prednisolone following radiotherapy for primary central nervous system lymphoma: a phase II study.
Shibamoto Y; Sasai K; Oya N; Hiraoka M
J Neurooncol; 1999 Apr; 42(2):161-7. PubMed ID: 10421074
[TBL] [Abstract][Full Text] [Related]
52. Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study.
Lai R; Abrey LE; Rosenblum MK; DeAngelis LM
Neurology; 2004 Feb; 62(3):451-6. PubMed ID: 14872029
[TBL] [Abstract][Full Text] [Related]
53. Non-Hodgkin's lymphoma in elderly patients: a phase II study of MCOP chemotherapy in patients aged 70 years or over with intermediate- or high-grade histology.
Bessell EM; Coutts A; Fletcher J; Toghill PJ; Moloney AJ; Ellis IO; Hulman G; Jenkins D
Eur J Cancer; 1994; 30A(9):1337-41. PubMed ID: 7999422
[TBL] [Abstract][Full Text] [Related]
54. [Primary cerebral non-Hodgkin's lymphoma. Intensive chemotherapy supported by crania radiotherapy].
Jensen MK; Skejø HP; Jensen MK
Ugeskr Laeger; 1996 Jul; 158(31):4413-5. PubMed ID: 8760000
[TBL] [Abstract][Full Text] [Related]
55. Chemotherapy as first treatment for primary malignant non-Hodgkin's lymphoma of the central nervous system preliminary data.
Boiardi A; Silvani A; Valentini S; Salmaggi A; Allegranza A; Broggi G
J Neurol; 1993 Dec; 241(2):96-100. PubMed ID: 7511159
[TBL] [Abstract][Full Text] [Related]
56. Stage IA non-Hodgkin's lymphoma of the Waldeyer's ring. Limited chemotherapy and radiation therapy versus radiation therapy alone.
Uematsu M; Kondo M; Hiramatsu H; Ikeda Y; Mikata S; Katayama M; Ito H; Kusano S; Kubo A
Acta Oncol; 1993; 32(6):675-8. PubMed ID: 8260187
[TBL] [Abstract][Full Text] [Related]
57. Treatment for primary CNS lymphoma: the next step.
Abrey LE; Yahalom J; DeAngelis LM
J Clin Oncol; 2000 Sep; 18(17):3144-50. PubMed ID: 10963643
[TBL] [Abstract][Full Text] [Related]
58. Outcome and patterns of failure in testicular lymphoma: a multicenter Rare Cancer Network study.
Zouhair A; Weber D; Belkacémi Y; Ketterer N; Dietrich PY; Villà S; Scandolaro L; Bieri S; Studer G; Delacretaz F; Girardet C; Mirimanoff RO; Ozsahin M;
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):652-6. PubMed ID: 11849786
[TBL] [Abstract][Full Text] [Related]
59. [Evaluation of the method of treating non-Hodgkin's lymphoma].
Katou H; Miyaguchi M; Sakai S; Yamauchi A; Kuwabara H; Sakamoto H
Nihon Jibiinkoka Gakkai Kaiho; 1994 Dec; 97(12):2239-46. PubMed ID: 7861296
[TBL] [Abstract][Full Text] [Related]
60. Therapy of primary central nervous system lymphoma with pre-irradiation methotrexate, cyclophosphamide, doxorubicin, vincristine, and dexamethasone (MCHOD).
Glass J; Shustik C; Hochberg FH; Cher L; Gruber ML
J Neurooncol; 1996 Dec; 30(3):257-65. PubMed ID: 8943101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
